Addex Therapeutics Files 6-K with Press Release
Ticker: ADXN · Form: 6-K · Filed: Jun 30, 2025 · CIK: 1574232
Sentiment: neutral
Topics: regulatory-filing, press-release, corporate-update
TL;DR
Addex Therapeutics filed a 6-K on 6/30/25, attaching a press release. Check for updates.
AI Summary
On June 30, 2025, Addex Therapeutics Ltd. filed a Form 6-K to report the issuance of a press release. This press release, dated June 30, 2025, is attached as Exhibit 99.1 and incorporated by reference into the filing. The filing also notes that Addex Therapeutics Ltd. files annual reports under Form 20-F.
Why It Matters
This filing indicates ongoing corporate communications and regulatory compliance for Addex Therapeutics Ltd., potentially containing updates relevant to investors.
Risk Assessment
Risk Level: low — This is a routine filing reporting the issuance of a press release, with no immediate financial or operational disclosures that suggest high risk.
Key Players & Entities
- Addex Therapeutics Ltd. (company) — Registrant
- June 30, 2025 (date) — Date of press release and filing
- Exhibit 99.1 (document) — Attached press release
- Form 20-F (document) — Annual report form
- Form 6-K (document) — Report type
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose is to report the issuance of a press release dated June 30, 2025, by Addex Therapeutics Ltd., which is attached as Exhibit 99.1.
When was the press release mentioned in the filing issued?
The press release was issued on June 30, 2025.
What is the Commission File Number for Addex Therapeutics Ltd.?
The Commission File Number for Addex Therapeutics Ltd. is 001-39179.
Does Addex Therapeutics Ltd. file annual reports under Form 20-F or Form 40-F?
Addex Therapeutics Ltd. files annual reports under cover of Form 20-F.
What registration statements is Exhibit 99.1 incorporated by reference into?
Exhibit 99.1 is incorporated by reference into the registration statement on Form F-3 (Registration No. 333-255089) and the registration statements on Form S-8 (Registration No. 333-255124 and No. 33).
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 30, 2025 regarding Addex Therapeutics Ltd. (ADXN).